MetLife Investment Management
MDWD icon

MetLife Investment Management’s MediWound MDWD Stock Holding History

MetLife Investment Management’s Portfolio MDWD Stock Details MDWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,908
Closed -$95.2K – 2927
2026
Q1 		$95.2K Hold
5,908
– – ﹤0.01% 2563
2025
Q4 		$109K Buy
+5,908
New +$108K ﹤0.01% 2566
2025
Q3 		– Sell
-5,181
Closed -$100K – 2890
2025
Q2 		$100K Hold
5,181
– – ﹤0.01% 2537
2025
Q1 		$80.4K Sell
5,181
-105
-2% -$1.88K ﹤0.01% 2609
2024
Q4 		$94.1K Buy
5,286
+340
+7% +$5.86K ﹤0.01% 2648
2024
Q3 		$89.3K Buy
+4,946
New +$90.3K ﹤0.01% 2667

Other funds holding MDWD

Investor AB
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
YLHM
Yelin Lapidot Holdings Management Tel Aviv, Israel $527M AUM 50.16% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $211M AUM 58.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MetLife Investment Management's MDWD Position: Q2 2026 in Review

MetLife Investment Management sold out of MediWound (MDWD) in Q2 2026, closing a stake of 5,908 shares — an estimated $95.2K sold.

MetLife Investment Management first reported a position in MDWD in Q3 2024 and held it in 6 quarters. The position peaked at $109K in Q4 2025. 78 funds tracked by Wall St. Rank hold MDWD as of Q2 2026.

  • MetLife Investment Management reported no remaining MediWound position as of Q2 2026 after selling out during the quarter.
  • MetLife Investment Management sold 5,908 MediWound shares in Q2 2026, an estimated $95.2K.
  • MetLife Investment Management first reported a position in MediWound in Q3 2024 and held it in 6 quarters.
  • MetLife Investment Management's MediWound position peaked at $109K in Q4 2025.
  • 78 funds tracked by Wall St. Rank held MediWound as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.